Clover Health Investments Corp

Clover Health Investments Corp (CLOV) Stock Analysis

$4.790

-0.020 (-0.42%)At close

Loading chart…
High
4.890
Open
4.760
VWAP
4.80
Volume
3.76M
Mkt Cap
645.37M
Low
4.730
Amount
18.05M
EV/EBITDA, TTM
17.36

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.

AI analysis of Clover Health Investments Corp (CLOV)

Buy

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

Valuation Metrics

The current forward P/E ratio for Clover Health Investments Corp (CLOV) is 37.74, compared to its 5-year average forward P/E of 3.43.

Forward P/E

Fair
5Y Average P/E
3.43
Current P/E
37.74
Overvalued
40.64
Undervalued
-33.78

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
10.95
Current EV/EBITDA
17.36
Overvalued
30.05
Undervalued
-8.15

Forward P/S

Fair
5Y Average P/S
0.55
Current P/S
0.72
Overvalued
0.88
Undervalued
0.22

Alphio AI Price Scenarios for CLOV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLOV

$3.66

Scenario price

B

Base

Base · 50%CLOV

$3.60

Scenario price

B

Bear

Bear · 25%CLOV

$3.51

Scenario price

Whales holding CLOV

G

GMT Capital Corp.

+ HoldingCLOV

+2.52%

3M Return

Events Timeline

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

2026-09-10 (ET)

16:30:00

Major Averages Close Broadly Lower as Oil Surpasses $100

12:30:00

Major Averages Broadly Lower as Oil Surpasses $100

12:30:00

Clover Health Shares Rise 9.1% to $4.74

News

CLOV FAQ — answered by Alphio AI

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

Community

More ↗
Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started